Latest Influencer Marketing News

AMCOR PLC has announced an ordinary dividend of USD 0.1275 per security for the quarter ending December 2024, payable on March 18, 2025. The dividend is unfranked and offers currency flexibility for investors.

Sigma Healthcare has received Federal Court approval for its acquisition of Chemist Warehouse, marking a pivotal step in its strategic expansion. The scheme is set to become legally effective on February 4, 2025, with implementation expected by February 12.

Duxton Water Limited reports a $22 million increase in its water portfolio value for December 2024, driven by strategic acquisitions and rising allocation prices amid persistent dry weather in the Murray-Darling Basin.

Syrah Resources faces significant operational disruption at its Balama graphite mine due to ongoing protests, declaring force majeure while advancing its US-based Vidalia facility amid strong EV market growth.

CurveBeam AI Limited reported a remarkable 150% increase in device purchase orders in Q2 FY25, driven by strong demand for its HiRise™M platform and a new commercial agreement with Stryker. The company is advancing validation of its Enhanced HiRise™ for robotic surgical systems, despite a regulatory delay for its BMD SaaS module.

5G Networks Limited has increased its on-market takeover offer for AuCyber Limited from 11 cents to 13.5 cents per share, marking its final bid ahead of the January 30 deadline.

Metrics Master Income Trust has announced an estimated unfranked dividend of AUD 0.0137 per unit, payable in February 2025, alongside a full Dividend Reinvestment Plan option.

Cobalt Blue Holdings has completed a non-renounceable entitlement issue, raising just over half a million dollars but leaving a significant shortfall of shares unclaimed. The company now holds discretion to place these shortfall shares within three months.

BKI Investment Company Limited reported a solid half-year performance for December 2024, maintaining stable revenue and lifting its fully franked dividend by 1%. The company also introduced a neutralised Dividend Reinvestment Plan to better align shareholder interests and capital structure.

Visioneering Technologies reports promising interim results from its PROTECT trial, showing significant control of myopia progression in children using NaturalVue® Multifocal lenses.